Clearside Biomedical, Inc.
CLSDNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CLSD. That does not mean none is planned.
Get an email about CLSD's next catalysts
Track Clearside Biomedical (CLSD) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
CLS-TA Suprachoriodal
Uveitis
CLS-AX
Neovascular Age-related Macular Degeneration
triamcinolone acetonide (Triesence®)
Uveitis
CLS-TA
Macular Edema
SC CLS-TA
Diabetic Macular Edema
Anti-VEGF
Neovascular Age-related Macular Degeneration
IVT Aflibercept
Diabetic Macular Edema
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CLS-TA Suprachoriodal | Phase 3 | Uveitis | - | - |
CLS-AX | Phase 2 | Neovascular Age-related Macular Degeneration | - | - |
triamcinolone acetonide (Triesence®) | Phase 2 | Uveitis | - | Patent 2040 |
CLS-TA | Phase 2 | Macular Edema | - | - |
SC CLS-TA | Phase 2 | Diabetic Macular Edema | - | - |
Anti-VEGF | Phase 2 | Neovascular Age-related Macular Degeneration | - | - |
IVT Aflibercept | Phase 2 | Diabetic Macular Edema | - | - |
Uveitis
5 drugs in this indication
Macular Edema
2 drugs in this indication
Neovascular Age-related Macular Degeneration
1 drug in this indication
Diabetic Macular Edema
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Clearside Biomedical, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Clearside Biomedical, Inc.'s (CLSD) pipeline across Phase 3, Phase 2. Its lead program is CLS-TA Suprachoriodal (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Clearside Biomedical, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Clearside Biomedical, Inc. (CLSD) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CLSD biotech catalysts?→
Add CLSD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Clearside Biomedical, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.